Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.
about
Adverse events associated with hormonal therapy for prostate cancerThe Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid HormonesRadioligand therapy of metastatic prostate cancer using 177Lu-PSMA-617 after radiation exposure to 223Ra-dichloride.Clinical significance of androgen secretion disorders in men with a malignancy.Management of complications of prostate cancer treatment.Clinical pearls in general internal medicine.Management of complications of androgen deprivation therapy in the older man.Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancerEfficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer.Assessment of an ethanolic seed extract of Picralima nitida ([Stapf] Th. and H. Durand) on reproductive hormones and its safety for use.Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications.Hematological changes during androgen deprivation therapyCardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.Low testosterone levels and the risk of anemia in older men and women.Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer.Metabolic sequelae associated with androgen deprivation therapy for prostate cancer.Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care?Effects of radiation and total androgen blockade on serum hemoglobin, testosterone, and erythropoietin in patients with localized prostate cancer.
P2860
Q24548201-2AD200C1-9241-4B0A-A1E5-1227BDA37E97Q26771431-84BC9C07-54CA-410B-9063-F0E397EB8AE9Q33441176-AFB555A4-ADAB-4020-B50D-C0F53C338500Q33840617-667496D3-2076-45A0-B9B9-55DE18318B3FQ33978360-8D1D48B8-CDE5-46BD-BD3C-58B68807FFA8Q34450962-C86E1572-012B-49B7-91AC-FAF1393D543CQ34782101-BC78D6C3-816D-47C8-9BE8-A7A36B43E5F9Q35202889-E6FE6D59-8DD6-4782-9510-9C42E3B335C1Q35441262-6791D34E-813E-418B-A180-220CD24C8FA3Q35689824-03399347-0113-4B67-AFB9-BE84A0ECAE99Q36333739-8D29FDE1-E6CE-460F-82F1-1FCD3C5AB500Q36776998-A962CD21-C932-4941-82EF-438DF655A8ECQ37074374-973E498E-10BA-4689-B0E9-E84B01F8D0D2Q37103095-5E9A5F20-B8CD-4D6C-A2C1-B6096B43582FQ37104301-20E785F9-89F0-4707-9B92-35A0F85834F5Q37124741-D57D1A8A-6454-4480-BFBE-9C00A329AFF3Q37431937-641C1F9F-3D47-4DD3-8B4D-F55B2D63A1B9Q38077183-27ECE0C3-4A6D-47FA-B1EB-85D4D2ADF2DAQ42140990-4296EE65-D557-4665-BBB6-1A669535AAC4
P2860
Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Anaemia associated with androg ...... ing combined hormone blockade.
@en
type
label
Anaemia associated with androg ...... ing combined hormone blockade.
@en
prefLabel
Anaemia associated with androg ...... ing combined hormone blockade.
@en
P2093
P1476
Anaemia associated with androg ...... ving combined hormone blockade
@en
P2093
P304
P356
10.1046/J.1464-410X.1997.00234.X
P577
1997-06-01T00:00:00Z